Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
NCT06579469 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-05-20
Summary
This study is being done to learn more about the short-term and long-term side effects of CAR-T cell therapy. Specifically, researchers want to know how often patients get infections, have delays in recovering blood cell counts and/or have damage to the nervous system.
Conditions
- B-ALL
- Hematologic Malignancy
- Solid Tumor
Sponsors & Collaborators
-
Rally Foundation for Childhood Cancer Research
collaborator OTHER -
St. Jude Children's Research Hospital
lead OTHER
Principal Investigators
-
Rebecca Epperly, MD · St. Jude Children's Research Hospital
Eligibility
- Max Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-20
- Primary Completion
- 2027-03-31
- Completion
- 2029-03-31
Countries
- United States
Study Locations
More Related Trials
-
Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
NCT00066469 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
NCT06839456 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
NCT05732961 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
CD19-Specific T Cells Post AlloSCT
NCT03579888 ·Status: TERMINATED ·Phase: PHASE1
-
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
NCT03842696 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
NCT03922724 ·Status: RECRUITING ·Phase: PHASE2
-
Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
NCT00005092 ·Status: COMPLETED ·Phase: PHASE1
-
Pegfilgrastim for Stem Cell Mobilization in Children (Meg-5)
NCT00751894 ·Status: UNKNOWN ·Phase: PHASE2
-
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children
NCT01858740 ·Status: COMPLETED ·Phase: PHASE2
-
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
NCT00619879 ·Status: COMPLETED
-
Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant
NCT01660347 ·Status: WITHDRAWN ·Phase: NA
-
High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma
NCT01840566 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
NCT02203903 ·Status: RECRUITING ·Phase: PHASE1
-
Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
NCT07162038 ·Status: RECRUITING ·Phase: PHASE1
-
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
NCT03314974 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies
NCT02639559 ·Status: COMPLETED ·Phase: PHASE2
-
Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cyclophosphamide and Rituximab
NCT01416974 ·Status: COMPLETED ·Phase: PHASE1
-
CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma
NCT03579927 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
NCT03779854 ·Status: RECRUITING ·Phase: PHASE2
-
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies
NCT03849651 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma
NCT00024128 ·Status: WITHDRAWN ·Phase: PHASE2
-
Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders
NCT00636909 ·Status: COMPLETED ·Phase: PHASE2
-
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma
NCT01815749 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
NCT00044954 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS
NCT00520468 ·Status: COMPLETED ·Phase: PHASE2